Twitter | Search | |
Stemina Biomarker
Stemina Biomarker Discovery is a metabolomics company focused on the discovery, development and commercialization of molecular biomarkers to improve drug safety
376
Tweets
532
Following
502
Followers
Tweets
Stemina Biomarker 22h
Zebrafish are a viable alternative for toxicology testing ( but only a human model will respond to chemical exposure like a human. See how our developmental tox assay performs vs. rodent, rabbit, & zebrafish results.
Reply Retweet Like
Stemina Biomarker Jun 14
Our friends at , the company that makes some of the cells we use in our assays, also produces cells that will be used in seminal Alzheimer’s research.
Reply Retweet Like
Stemina Biomarker Jun 12
What if students of all disciplines were taught to think like scientists? This author argues that we’d have a more thoughtful society filled with critical thinkers and people who value proven, unbiased evidence. Not bad!
Reply Retweet Like
Stemina Biomarker Jun 7
The collaboration called Toxicology in the 21st Century, or , launched its strategic plan last month. Tox21 has already accomplished some of its goals, like screening thousands of chemicals and publishing the results in peer-reviewed articles.
Reply Retweet Like
Stemina Biomarker Jun 5
A new resource from the asks questions we’ve also pondered: Why aren’t alternatives to animal testing the norm? When will they become the standard?
Reply Retweet Like
Stemina Biomarker May 31
A new study shows that high blood pressure in babies can be traced to a mother’s exposure to air pollution during pregnancy.
Reply Retweet Like
Stemina Biomarker May 29
A task force calls for more pregnant women in clinical trials. Another step to protect mom and baby: test compounds in a human system, as we do. Human response is more predictive.
Reply Retweet Like
Stemina Biomarker May 23
In a push to strengthen safety, the has received fewer registrations for substances than expected. REACH, the law requiring the registrations, is intended to shift the responsibility of producing safer chemicals to the companies.
Reply Retweet Like
Stemina Biomarker May 16
Our Assoc Dir of Toxicology, Jessica Palmer, will attend the Midwest Regional Chapter Spring 2018 Meeting of on Friday. Look for her to ask about our new cardiotoxicity assay!
Reply Retweet Like
Stemina Biomarker May 14
A 2016 change to chemical safety law has resulted in a staggering increase in animal testing. In 2015, EPA tests involved ~9,000 animals; in 2017, 76,000. Alternatives to animal testing deserve consideration!
Reply Retweet Like
Stemina Biomarker May 9
Our cardiotoxicity assay provides an indication of cardiotoxicity and identifies functional or structural caridotoxicants with a single assay. Read our poster, presented at SOT 2018, for more:
Reply Retweet Like
Stemina Biomarker May 7
Some effective chemotherapeutic agents are also quite cardiotoxic. In this paper, researchers strive to understand why this is the case and what can be done to limit cardiotoxicity.
Reply Retweet Like
Stemina Biomarker May 3
In a recent paper, HTTK assays and IVIVE methods were evaluated for their accuracy to screen environmentally-relevant chemicals. Previous studies have focused on using these methods to screen pharmaceuticals.
Reply Retweet Like
Stemina Biomarker May 1
The potential for developmental neurotoxicity is unknown for many chemicals. Some groups are trying to change that, while reducing animal use. Combining results from organ-specific assays can provide information on multiple types of toxicity.
Reply Retweet Like
Stemina Biomarker Apr 25
A new article in Alternatives to Animal Experimentation shares thoughts on how to integrate the current systemic toxicology testing with alternative approaches.
Reply Retweet Like
Stemina Biomarker Apr 23
A new paper uses an adverse outcome pathway (AOP) to demonstrate a causal link between pesticide use and the development of Parkinson’s disease.
Reply Retweet Like
Stemina Biomarker Apr 20
Tox 21, or Toxicology in the 21st Century, is a federal consortium moving the US toward in vitro alternatives to the traditional tests. A cross-partner projects in this paper is evaluating our devTOX quickPredict assay.
Reply Retweet Like
Stemina Biomarker Apr 18
Time is running out! Request a quote by Friday, 4/20 and get 10% off your order. Both devTOX quickPredict or the new Cardio quickPredict qualify. Email gwentling@stemina.com to get started!
Reply Retweet Like
Stemina Biomarker Apr 11
Early signs indicate in vivo alternatives have good concordance with standard in vivo tests for toxicity, EU-ToxRisk reports.
Reply Retweet Like
Stemina Biomarker Apr 5
Our assays, devTOX quickPredict and newcomer Cardio quickPredict, are 10% off if ordered by April 20th! Email gwentling@stemina.com to request a quote!
Reply Retweet Like